Augustine Therapeutics
Description: Augustine Therapeutics develops novel HDAC6 inhibitors & GABABR1a activators to treat neurological diseases like CMT, aiming to protect nerves & repair myelin.
Country: Belgium
Based in: Gent
Founded: 2019
Funding Stage: Seed
Tags: ['Biopharma', 'Biotechnology', 'Pharmaceutical']
ACCESS DIRECTORY
Details about how we process your information are available in our Privacy Policy.
